Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors

Research output: Contribution to journal › Editorial › Research › peer-review

Standard

Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors. / Franciosa, Giulia; Olsen, Jesper V.

In: OncoTarget, Vol. 14, 2023, p. 281-283.

Research output: Contribution to journal › Editorial › Research › peer-review

Harvard

Franciosa, G & Olsen, JV 2023, 'Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors', OncoTarget, vol. 14, pp. 281-283. https://doi.org/10.18632/oncotarget.28392

APA

Franciosa, G., & Olsen, J. V. (2023). Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors. OncoTarget, 14, 281-283. https://doi.org/10.18632/oncotarget.28392

Vancouver

Franciosa G, Olsen JV. Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors. OncoTarget. 2023;14:281-283. https://doi.org/10.18632/oncotarget.28392

Author

Franciosa, Giulia ; Olsen, Jesper V. / Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors. In: OncoTarget. 2023 ; Vol. 14. pp. 281-283.

Bibtex

@article{ca2d5b9b3d9446d29081c5b372fdd0c6,
title = "Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors",
keywords = "Humans, Phosphorylation, Cell Line, Tumor, Protein Kinase Inhibitors/pharmacology, Tyrosine, Protein Tyrosine Phosphatase, Non-Receptor Type 11/genetics, Enzyme Inhibitors/pharmacology",
author = "Giulia Franciosa and Olsen, {Jesper V}",
year = "2023",
doi = "10.18632/oncotarget.28392",
language = "English",
volume = "14",
pages = "281--283",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",

}

RIS

TY - JOUR

T1 - Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors

AU - Franciosa, Giulia

AU - Olsen, Jesper V

PY - 2023

Y1 - 2023

KW - Humans

KW - Phosphorylation

KW - Cell Line, Tumor

KW - Protein Kinase Inhibitors/pharmacology

KW - Tyrosine

KW - Protein Tyrosine Phosphatase, Non-Receptor Type 11/genetics

KW - Enzyme Inhibitors/pharmacology

U2 - 10.18632/oncotarget.28392

DO - 10.18632/oncotarget.28392

M3 - Editorial

C2 - 36999992

VL - 14

SP - 281

EP - 283

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

ER -

ID: 346586124